화학공학소재연구정보센터
Macromolecular Research, Vol.30, No.11, 811-819, November, 2022
In situ Forming Hydrogel Crosslinked with Tetronic Micelle for Controlled Delivery of Hydrophobic Anticancer Drug
E-mail:
For cancer treatment, anti-cancer hydrophobic drugs such as paclitaxel (PTX) are usually intravenously administrated as a systemic delivery which has low targeting efficiency, rapid clearance, and non-specific side effects. Although local chemotherapy using biomaterials to overcome these limitations has attracted attention, the poor water solubility of hydrophobic drugs is still challenging for controlled delivery and bioavailability of drugs. In this study, an in situ forming hydrogel crosslinked with PTX-loaded micelle was developed for enhanced stability and controlled delivery of PTX. Tetronic-tyramine micelle (TTAm) is a phenol-conjugated Tetronic micelle (TETm) that can facilitate enzymatic crosslinking between TTAm and gelatin- hydroxyphenyl propionic acid (GH) hydrogels to produce GH hydrogels crosslinked with TTAm (TTAm/GH) for controllable physicochemical properties such as gelation time, stiffness, and swelling ratio. The TTAm/GH showed PTX release pattern for 4 weeks in a controlled manner, whereas TETm/GH and GH only had limited release profiles. Moreover, TTAm/GH showed cytocompatibility and improved drug efficacy against cancer cells compared to the control group. Such in situ forming GH hydrogel crosslinked with Tetronic micelle is expected to be a promising local hydrophobic anti-cancer drug carrier for cancer treatment.
  1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A, CA Cancer J. Clin., 68, 394 (2018)
  2. Yao X, Chen L, Chen X, He C, Zheng H, Chen X, Colloids Surf. B: Biointerfaces, 121, 36 (2014)
  3. Wang J, Xu W, Li S, Qiu H, Li Z, Wang C, Wang X, Ding J, J. Biomed. Nanotechnol., 14, 2102 (2018)
  4. Qin L, Zhang F, Lu X, Wei X, Wang J, Fang X, Si D, Wang Y, Zhang C, Yang R, Liu C, Liang W, J. Control. Release, 171, 133 (2013)
  5. Ta HT, Dass CR, Dunstan DE, J. Control. Release, 126, 205 (2008)
  6. Lundqvist EA, Fujiwara K, Seoud M, Int. J. Gynaecol. Obstet., 131, S146 (2015)
  7. Tosti A, Piraccini BM, Vincenzi C, Misciali C, Br. J. Dermatol., 152, 1056 (2005)
  8. Padma VV, BioMedicine, 5, 19 (2015)
  9. Sanna V, Pala N, Sechi M, Int. J. Nanomed., 9, 467 (2014)
  10. Celikoglu F, Celikoglu SI, Goldberg EP, Cancer Ther., 6, 545 (2008)
  11. Otani Y, Yoshida I, Ishikawa S, Ohtaki A, Ohki S, Sakata S, Totsuka O, Morishita Y, Jpn. J. Clin. Oncol., 26, 476 (1996)
  12. Christman KL, Vardanian AJ, Fang Q, Sievers RE, Fok HH, Lee RJ, J. Am. College Cardiol., 44, 654 (2004)
  13. Jeong B, Kim SW, Bae YH, Adv. Drug Deliv. Rev., 64, 154 (2012)
  14. Yu L, Ding J, Chem. Soc. Rev., 37, 1473 (2008)
  15. Gu D, O'Connor AJ, Ladewig K, Expert Opin. Drug Deliv., 14, 879 (2017)
  16. McKenzie M, Betts D, Suh A, Bui K, Kim LD, Cho H, Molecules, 20, 20397 (2015)
  17. Peng K, Tomatsu I, Korobko AV, Kros A, Soft Matter, 6, 85 (2010)
  18. Lu Y, Zhang E, Yang J, Cao Z, Nano Res., 11, 4985 (2018)
  19. Lu Y, Gao X, Cao M, Wu B, Su L, Chen P, Miao J, Wang S, Xia R, Qian J, Colloids Surf. B: Biointerfaces, 189, 110830 (2020)
  20. Wang L, Zhang J, Song M, Tian B, Li K, Liang Y, Han J, Wu Z, Colloids Surf. B: Biointerfaces, 152, 1 (2017)
  21. Talelli M, Barz M, Rijcken CJ, Kiessling F, Hennink WE, Lammers T, Nano Today, 10, 93 (2015)
  22. Sun X, Wang G, Zhang H, Hu S, Liu X, Tang J, Shen Y, ACS Nano, 12, 6179 (2018)
  23. Owen SC, Chan DP, Shoichet MS, Nano Today, 7, 53 (2012)
  24. Grillo R, Dias FFV, Querobino SM, Alberto-Silva C, Fraceto LF, de Paula E, de Araujo DR, Colloids Surf. B: Biointerfaces, 174, 56 (2019)
  25. Kabiri M, Kamal SH, Pawar SV, Roy PR, Derakhshandeh M, Kumar U, Hatzikiriakos SG, Hossain S, Yadav VG, Drug Deliv. Transl. Res., 8, 484 (2018)
  26. Noda T, Okuda T, Mizuno R, Ozeki T, Okamoto H, Biol. Pharm. Bull., 41, 937 (2018)
  27. Daly AC, Riley L, Segura T, Burdick JA, Nat. Rev. Mater., 5, 20 (2020)
  28. Sivakumaran D, Maitland D, Hoare T, Biomacromolecules, 12, 4112 (2011)
  29. Le Thi P, Son JY, Lee Y, Ryu SB, Park KM, Park KD, Macromol. Res., 28, 400 (2020)
  30. Kim BY, Park KM, Joung YK, Park KD, J. Bioact. Compat. Polym., 27, 185 (2012)
  31. Tibbitt MW, Anseth KS, Biotechnol. Bioeng., 103, 655 (2009)
  32. Chiappetta DA, Sosnik A, Eur. J. Pharm. Biopharm., 66, 303 (2007)
  33. Fernandez-Tarrio M, Yañez F, Immesoete K, Alvarez-Lorenzo C, Concheiro A, AAPS Pharmscitech, 9, 471 (2008)
  34. Lee Y, Bae JW, Oh DH, Park KM, Chun YW, Sung HJ, Park KD, J. Mater. Chem. B, 1, 2407 (2013)
  35. Oh DH, Thi PL, Park KD, Macromol. Res., 30, 190 (2022)
  36. Yang YQ, Zhao B, Li ZD, Lin WJ, Zhang CY, Guo XD, Wang JF, Zhang LJ, Acta Biomater., 9, 7679 (2013)
  37. Khanmohammadi M, Dastjerdi MB, Ai A, Ahmadi A, Godarzi A, Rahimi A, Ai J, Biomater. Sci., 6, 1286 (2018)
  38. Lee F, Bae KH, Kurisawa M, Biomed. Mater., 11, 014101 (2015)
  39. McKenzie M, Betts D, Suh A, Bui K, Kim LD, Cho H, Molecules, 20, 20397 (2015)
  40. Park KM, Lee Y, Son JY, Oh DH, Lee JS, Park KD, Biomacromolecules, 13, 604 (2012)
  41. Yan S, Ren J, Jian Y, Wang W, Yun W, Yin J, Biomacromolecules, 19, 4554 (2018)
  42. Kirschner CM, Anseth KS, Acta Mater., 61, 931 (2013)
  43. Li J, Mooney DJ, Nat. Rev. Mater., 1 (2016)
  44. Ito T, Takami T, Uchida Y, Murakami Y, Colloids Surf. B: Biointerfaces, 163, 257 (2018)
  45. Amsden B, Macromolecules, 31, 8382 (1998)